Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander G Thompson

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|January 20, 2017
A risk stratifying tool to facilitate safe late-stage percutaneous endoscopic gastrostomy in ALSAlexander G Thompson, Victoria Blackwell, Rachael Marsden, et al.
Clinical Proteomics|August 22, 2020
CSF extracellular vesicle proteomics demonstrates altered protein homeostasis in amyotrophic lateral sclerosisAlexander G Thompson, Elizabeth Gray, Imre Mäger, et al.
Annals of Neurology|January 14, 2018
Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosisAlexander G Thompson, Elizabeth Gray, Marie-Laëtitia Thézénas, et al.
Proteomics|November 10, 2018
UFLC-Derived CSF Extracellular Vesicle Origin and ProteomeAlexander G Thompson, Elizabeth Gray, Imre Mager, et al.
Brain Communications|July 3, 2020
Identification of a potential non-coding RNA biomarker signature for amyotrophic lateral sclerosisGreig Joilin, Elizabeth Gray, Alexander G Thompson, et al.
Brain Communications|May 23, 2024
The cortical neurophysiological signature of amyotrophic lateral sclerosisMichael Trubshaw, Chetan Gohil, Katie Yoganathan, et al.
NPJ Parkinson'S Disease|July 4, 2026
Dopamine replacement therapy modulates DDC, prolactin and AOC3 levels in Parkinson's diseaseLudo van Hillegondsberg, Shahzad Ahmad, Tanja Zerenner, et al.
Annals of Neurology|November 16, 2024
Elevated Cerebrospinal Fluid Ubiquitin Carboxyl-Terminal Hydrolase Isozyme L1 in Asymptomatic C9orf72 Hexanucleotide Repeat Expansion CarriersElizabeth R Dellar, Iolanda Vendrell, Benazir Amein, et al.
Human Brain Mapping|October 3, 2025
Divergent Brain Network Activity in Asymptomatic C9orf72 and SOD1 Variant Carriers Compared With Established Amyotrophic Lateral SclerosisMichael Trubshaw, Chetan Gohil, Evan Edmond, et al.
Neurobiology of Disease|August 18, 2020
An ALS-linked mutation in TDP-43 disrupts normal protein interactions in the motor neuron response to oxidative stressEmily Feneberg, David Gordon, Alexander G Thompson, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|January 20, 2017
A risk stratifying tool to facilitate safe late-stage percutaneous endoscopic gastrostomy in ALSAlexander G Thompson, Victoria Blackwell, Rachael Marsden, et al.
Clinical Proteomics|August 22, 2020
CSF extracellular vesicle proteomics demonstrates altered protein homeostasis in amyotrophic lateral sclerosisAlexander G Thompson, Elizabeth Gray, Imre Mäger, et al.
Annals of Neurology|January 14, 2018
Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosisAlexander G Thompson, Elizabeth Gray, Marie-Laëtitia Thézénas, et al.
Proteomics|November 10, 2018
UFLC-Derived CSF Extracellular Vesicle Origin and ProteomeAlexander G Thompson, Elizabeth Gray, Imre Mager, et al.
Brain Communications|July 3, 2020
Identification of a potential non-coding RNA biomarker signature for amyotrophic lateral sclerosisGreig Joilin, Elizabeth Gray, Alexander G Thompson, et al.
Brain Communications|May 23, 2024
The cortical neurophysiological signature of amyotrophic lateral sclerosisMichael Trubshaw, Chetan Gohil, Katie Yoganathan, et al.
NPJ Parkinson'S Disease|July 4, 2026
Dopamine replacement therapy modulates DDC, prolactin and AOC3 levels in Parkinson's diseaseLudo van Hillegondsberg, Shahzad Ahmad, Tanja Zerenner, et al.
Annals of Neurology|November 16, 2024
Elevated Cerebrospinal Fluid Ubiquitin Carboxyl-Terminal Hydrolase Isozyme L1 in Asymptomatic C9orf72 Hexanucleotide Repeat Expansion CarriersElizabeth R Dellar, Iolanda Vendrell, Benazir Amein, et al.
Human Brain Mapping|October 3, 2025
Divergent Brain Network Activity in Asymptomatic C9orf72 and SOD1 Variant Carriers Compared With Established Amyotrophic Lateral SclerosisMichael Trubshaw, Chetan Gohil, Evan Edmond, et al.
Neurobiology of Disease|August 18, 2020
An ALS-linked mutation in TDP-43 disrupts normal protein interactions in the motor neuron response to oxidative stressEmily Feneberg, David Gordon, Alexander G Thompson, et al.
Pageof 5